Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 56176 - 56200 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Panobinostat	Approved Investigational	FZD7	8324	upregulated	panobinostat results in increased expression of FZD7 mRNA	2q33.1	A21037
Panobinostat	Approved Investigational	GABRB2	2561	upregulated	panobinostat results in increased expression of GABRB2 mRNA	5q34	A21037
Panobinostat	Approved Investigational	GABRB3	2562	upregulated	panobinostat results in increased expression of GABRB3 mRNA	15q12	A21037
Panobinostat	Approved Investigational	GAD1	2571	upregulated	panobinostat results in increased expression of GAD1 mRNA	2q31.1	A21037
Panobinostat	Approved Investigational	GADD45A	1647	upregulated	panobinostat results in increased expression of GADD45A mRNA	1p31.3	A23577 A21037
Panobinostat	Approved Investigational	GADD45B	4616	upregulated	panobinostat results in increased expression of GADD45B mRNA	19p13.3	A21037
Panobinostat	Approved Investigational	GADD45G	10912	upregulated	panobinostat results in increased expression of GADD45G mRNA	9q22.2	A23577
Panobinostat	Approved Investigational	GALNT18	374378	upregulated	panobinostat results in increased expression of GALNT18 mRNA	11p15.4	A21037
Panobinostat	Approved Investigational	GALNT3	2591	upregulated	panobinostat results in increased expression of GALNT3 mRNA	2q24.3	A21037
Panobinostat	Approved Investigational	GAP43	2596	upregulated	panobinostat results in increased expression of GAP43 mRNA	3q13.31	A21037
Panobinostat	Approved Investigational	GAS7	8522	upregulated	panobinostat results in increased expression of GAS7 mRNA	17p13.1	A21037
Panobinostat	Approved Investigational	GATA2	2624	upregulated	panobinostat results in increased expression of GATA2 mRNA	3q21.3	A21037
Panobinostat	Approved Investigational	GATA3	2625	upregulated	panobinostat results in increased expression of GATA3 mRNA	10p14	A21037
Panobinostat	Approved Investigational	GATA4	2626	downregulated	panobinostat results in decreased expression of GATA4 mRNA	8p23.1	A21037
Panobinostat	Approved Investigational	GBX2	2637	upregulated	panobinostat results in increased expression of GBX2 mRNA	2q37.2	A21037
Panobinostat	Approved Investigational	GCHFR	2644	upregulated	panobinostat results in increased expression of GCHFR mRNA	15q15.1	A21037
Panobinostat	Approved Investigational	GJA3	2700	upregulated	panobinostat results in increased expression of GJA3 mRNA	13q12.11	A21037
Panobinostat	Approved Investigational	GKAP1	80318	downregulated	panobinostat results in decreased expression of GKAP1 mRNA	9q21.32	A21037
Panobinostat	Approved Investigational	GLCCI1	113263	downregulated	panobinostat results in decreased expression of GLCCI1 mRNA	7p21.3	A21037
Panobinostat	Approved Investigational	GLIS3	169792	downregulated	panobinostat results in decreased expression of GLIS3 mRNA	9p24.2	A21037
Panobinostat	Approved Investigational	GLRX2	51022	upregulated	panobinostat results in increased expression of GLRX2 mRNA	1q31.2	A21037
Panobinostat	Approved Investigational	GLS	2744	upregulated	panobinostat results in increased expression of GLS mRNA	2q32.2	A21037
Panobinostat	Approved Investigational	GNAS	2778	upregulated	panobinostat results in increased expression of GNAS mRNA	20q13.32	A21037
Panobinostat	Approved Investigational	GNG11	2791	upregulated	panobinostat results in increased expression of GNG11 mRNA	7q21.3	A21037
Panobinostat	Approved Investigational	GNG8	94235	downregulated	panobinostat results in decreased expression of GNG8 mRNA	19q13.32	A21037

Displaying entries 56176 - 56200 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability